Page 259 - Pagetit
P. 259

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Hall W, Carter L (2002) Ethical and policy issues in trialing and using a cocaine
                   vaccine to treat and prevent cocaine dependence. Bulletin of the World Health
                   Organization, (in press).
                   Heath AC (1995) Genetic influences on alcoholism risk: a review of adoption and
                   twin studies. Alcohol Health and Research World, 19:166–171.
                   Hjern A, Lindblad F, Vinnerljung B (2002) Suicide, psychiatric illness, and social
                   maladjustment in intercountry adoptees in Sweden: a cohort study. Lancet,
                   360:443–448.
                   Horton R (1997) Medical editors trial amnesty. Lancet, 350:756.
                   Hser YI et al. (2001) A 33-year follow up of narcotic addicts. Archives of General
                   Psychiatry, 58:503–508.
                   Inciardi JA, McBride DC (1991) Treatment alternatives to street crime: history,
                   experiences and issues. Rockville, MD, National Institute of Drug Abuse.
                   International Federation of Red Cross and Red Crescent Societies and Francois-
                   Xavier Bagnoud Center for Health and Human Rights (1999) Human rights: an
                   introduction. In: Mann JM et al., eds. Health and human rights: a reader. London,
                   Routledge:21–28.
                   Johnson MW, Ettinger RH (2000) Active cocaine immunization attenuates the
                   discriminative properties of cocaine.  Experimental and Clinical
                   Psychopharmacology, 8:163–167.
                   Jonsen AR (1998) The birth of bioethics. Oxford, Oxford University Press.
                   Kaebnick GE (2000) Vaccinations against bad habits. Hastings Center Report,
                   30:48.
                   Kandel DB, Chen K (2000) Types of marijuana users by longitudinal course.
                   Journal of Studies on Alcohol, 61:367–378.
                   Kessler RC et al. (1994) Lifetime and 12-month prevalence of DSM-III-R
                   psychiatric disorders in the United States: results from the National Comorbidity
                   Survey. Archives of General Psychiatry, 51:8–19.
                   Kling MA et al. (2000) Opioid receptor imaging with positron emission
                   tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin
                   addicts. Journal of Pharmacology and Experimental Therapeutics, 295:1070–1076.
                   Leshner AI (1997) Addiction is a brain disease, and it matters. Science, 278:45–47.
                   Leukefeld CG, Tims FM (1988) Compulsory treatment: a review of the findings.
                   In: Leukefeld CG, Tims FM, eds. Compulsory treatment of drug abuse. Rockville,
                   MD, National Institute of Drug Abuse:236–251.
                   Levy F (1997) Attention deficit hyperactivity disorder. British Medical Journal,
                   315:894–895.
                   Lynskey MT, Hall W (2001) Attention deficit hyperactivity disorder and substance
                   use disorders: is there a causal link? Addiction, 96:815–822.
                   McGlashan TH (2001) Psychosis treatment prior to psychosis onset: ethical issues.
                   Schizophrenia Research, 51:47–54.
                   McGorry PD, Yung A, Phillips L (2001) Ethics and early intervention in psychosis:
                   keeping up the pace and staying in step. Schizophrenia Research, 51:17–29.


                                                  238




          Chapter_7                238                             19.1.2004, 11:51
   254   255   256   257   258   259   260   261   262   263   264